Rockwell Medical (RMTI) Accumulated Expenses (2010 - 2026)

Rockwell Medical (RMTI) has 17 years of Accumulated Expenses data on file, last reported at $3.2 million in Q1 2026.

• Quarterly Accumulated Expenses fell 30.97% year-over-year to $3.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.2 million (down 30.97% YoY) and the FY2025 annual result came in at $4.3 million, down 30.88% from the prior year.
• Accumulated Expenses retreated to $3.2 million in Q1 2026, from $4.3 million in the prior quarter.
• In the past five years, Accumulated Expenses ranged from a high of $7.7 million in Q4 2022 to a low of $3.2 million in Q1 2026.
• A 5-year average of $5.2 million and a median of $4.7 million in 2022 frame the typical range for Accumulated Expenses.
• Annual changes were most pronounced in 2024 — Accumulated Expenses surged 63.91% — and 2025, when it slumped 38.55%.
• Tracing RMTI's Accumulated Expenses over 5 years: stood at $7.7 million in 2022, then slipped by 7.18% to $7.1 million in 2023, then slipped by 12.23% to $6.3 million in 2024, then tumbled by 30.88% to $4.3 million in 2025, then declined by 27.14% to $3.2 million in 2026.
• The last three Accumulated Expenses figures came in at $3.2 million (Q1 2026), $4.3 million (Q4 2025), and $3.9 million (Q3 2025), per Business Quant data.